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L. Brent Mitchell, MD,* Darlene Ramadan, BSN,* Sandeep G. Aggarwal, MD,*
Catherine Noullett, RN,* Allie Van Schaik, RN,‡ Ryan T. Mitchell, BSC,* Mariko A. Shibata, BSC,*
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Gregory Schnell, MD,* Anne M. Gillis, MD,* Robert S. Sheldon, MD, PHD,*
Gordon H. Fick, PHD,† Henry J. Duff, MD,* for the REFINE Investigators
Calgary and Edmonton, Canada
Objectives This study sought to determine whether combined assessment of autonomic tone plus cardiac electrical sub-
strate identifies most patients at risk of serious events after myocardial infarction (MI) and to compare assess-
ment at 2 to 4 weeks versus 10 to 14 weeks after MI.
Background Methods to identify most patients at risk of serious events after MI are required.
Methods Patients (n  322) with an ejection fraction (EF) 0.50 in the initial week after MI were followed up for a me-
dian of 47 months. Serial assessment of autonomic tone, including heart rate turbulence (HRT), electrical sub-
strate, including T-wave alternans (TWA), and EF was performed, interpreted blinded, and categorized using pre-
specified cut-points where available. The primary outcome was cardiac death or resuscitated cardiac arrest. All-
cause mortality and fatal or nonfatal cardiac arrest were secondary outcomes.
Results Mean EF significantly increased over the initial 8 weeks after MI. Testing 2 to 4 weeks after MI did not reliably
identify patients at risk, whereas testing at 10 to 14 weeks did. The 20% of patients with impaired HRT, abnor-
mal exercise TWA, and an EF 0.50 beyond 8 weeks post-MI had a 5.2 (95% confidence interval [CI] 2.4 to
11.3, p  0.001) higher adjusted risk of the primary outcome. This combination identified 52% of those at risk,
with good positive (23%; 95% CI 17% to 26%) and negative (95%; 95% CI 93% to 97%) accuracy. Similar results
were observed for the secondary outcomes.
Conclusions Impaired HRT, abnormal TWA, and an EF 0.50 beyond 8 weeks after MI reliably identify patients at risk of seri-
ous events. (Assessment of Noninvasive Methods to Identify Patients at Risk of Serious Arrhythmias After a
Heart Attack; http://www.clinicaltrials.gov/ct/show/NCT00399503?order1; NCT00399503) (J Am Coll
Cardiol 2007;50:2275–84) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.08.042c
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oatients who survive a myocardial infarction (MI), particu-
arly those with residual left ventricular (LV) dysfunction,
re at risk of serious events (1,2). Although the implantable
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ccepted August 13, 2007.ardioverter-defibrillator (ICD) reduces mortality late after
I (3,4), it has not been shown to improve survival early
fter MI (5–7). The explanations for the lack of benefit with
CD therapy are complex, but may relate to LV remodeling
r other time-dependent effects (8). The lack of benefit may
lso be related to a higher risk of nonsudden versus sudden
eath in the initial 12 to 18 months after MI (1).
See page 2291
Reliable identification of most MI survivors at risk of
erious events has remained elusive. Noninvasive measures
f autonomic tone (9,10) and cardiac electrical substrate
11–13) have been developed to identify patients at risk of
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ter MI. Although marked abnor-
malities in autonomic tone alone
identify patients at risk, this ap-
proach is limited by low sensitiv-
ity (9,10,14). Combining multi-
ple measures of autonomic tone
(15,16) or combining multiple
measures of electrical substrate
(17) has not been shown to im-
prove diagnostic accuracy. Com-
bining measures of autonomic
tone with measures of electrical
substrate may enhance risk as-
sessment (15,18), but this strategy
remains unproven in the era of
contemporary post-MI manage-
ment (19).
The REFINE (Risk Estima-
tion Following Infarction, Non-
invasive Evaluation) cohort study
was designed to evaluate the util-
ity of combined assessment of
autonomic tone plus cardiac elec-
rical substrate to identify the majority of patients at risk
or cardiac death or resuscitated cardiac arrest after MI
nd to determine the optimal time to assess risk early
fter MI.
Figure 1 Patient Selection and Outcomes
A total of 322 patients with residual left ventricular dysfunction in the initial week
population, most of whom were deemed ineligible due to preserved left ventricular
testing. During 47 months of follow-up, 30 deaths were observed. Of these, 22 we
cardiac arrests occurred, only 2 of which were in patients with an implantable card
come are shown in blue.
Abbreviations
and Acronyms
AUC  area under the
receiver-operator
characteristic curve
BRS  baroreflex
sensitivity
CI  confidence interval
ECG  electrocardiograph/
electrocardiographic
HRT  heart rate
turbulence
HRV  heart rate variability
ICD  implantable
cardioverter-defibrillator
LV  left ventricular
LVEF  left ventricular
ejection fraction
MI  myocardial infarction
TWA  T-wave alternans
VPB  ventricular
premature beatsethods
ecruitment. Participants were enrolled from 6 Canadian
ospitals, representing 4 community-based and 2 tertiary
eferral institutions. The ethics review board at each insti-
ution approved the protocol. All patients provided written,
nformed consent. Patients were enrolled from May 2001
hrough July 2004. Follow-up was completed in December
006.
Patients were considered eligible if they had a confirmed
I (20) and a left ventricular ejection fraction (LVEF)
0.40 in the initial 48 h of the index MI or an LVEF
0.50 measured beyond the initial 48 h. Inclusion was
imited to those with at least mild LV dysfunction because
atients with preserved LV function after MI are at ex-
remely low risk of serious events (9). Patients with perma-
ent atrial fibrillation, a ventricular paced rhythm, a previ-
usly implanted ICD, or a clinical indication for an ICD at
he time of enrollment (21) were ineligible. Participant flow
s detailed in Figure 1. Most individuals excluded were
eemed ineligible because of an LVEF 0.50 in the initial
eek after MI. Outcome data on excluded patients were not
rospectively collected.
esting details. All 322 patients underwent assessment of
arameters at 2 to 4 weeks (acute) and at 10 to 14 weeks
nonacute) after MI. Test results were not disclosed to
articipants or their treating physicians. Participants under-
ent a submaximal exercise test to assess repolarization
myocardial infarction completed serial testing. They were enrolled from a larger
on, a serious comorbid illness, or an inability or unwillingness to undergo serial
egorized as cardiac and 17 as cardiac arrhythmic. Additionally, 7 resuscitated
er-defibrillator (ICD) at the time of the event. Events comprising the primary out-after a
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igh-resolution digital electrocardiographic (ECG) record-
ng, from which signal-averaged QRS width (18) and
olter TWA were measured (13). Participants then under-
ent phenylephrine-induced baroreflex sensitivity (BRS)
esting (9). An 18- to 24-h digital ambulatory ECG
ecording was then performed to assess heart rate variability
HRV) (23) and heart rate turbulence (HRT) (10). The
cheduled dose of beta-blocker immediately before testing
as delayed to facilitate achievement of the desired heart
ate on the exercise test. The LVEF was assessed in the
nitial week after MI using echocardiography (156 patients),
ontrast ventriculography (140 patients), or radionuclide
entriculography (26 patients). All 322 patients underwent
ssessment of LVEF via radionuclide ventriculography at 8
eeks to 10 weeks after MI.
ichotomy limits. The dichotomy limits used to define
mpairment were chosen to optimize sensitivity because
raditional dichotomy limits do not optimally predict events
hen combined (24). The pre-specified values for defining
bnormal HRV were standard deviation of intervals values
105 versus 105 ms (23). Impaired BRS was defined by
n average slope of 6.1 versus 6.1 ms/mm Hg (9).
ltered HRT was defined by abnormalities in either HRT
nset or slope versus both parameters being normal (10).
he 14 (4%) patients without ventricular premature beats
VPB) at the 2- to 4-week (acute) and the 22 (7%) patients
ithout VPB at the 10- to 14-week (nonacute) early
ost-MI test visits were categorized as having normal HRT
25). The pre-specified definitions for abnormal electrical
ubstrate were an increased signal-averaged QRS duration
f 114 versus 114 ms (18), and a non-negative versus
egative exercise TWA result (26,27). Given the lack of
rior data for the Holter TWA method, receiver-operator
haracteristic curves were generated using the continuous
ata over a 32-beat window as the raw signal minus the
oise and as the raw where the signal to noise ratio was
1.2. A cutoff of 5 versus 5 V for the Holter TWA
ethod using either method provided similar sensitivity and
pecificity to that achieved with exercise TWA in predicting
he secondary outcome of fatal or nonfatal cardiac arrest at
he nonacute test visit. A cut point of 0.50 was used to
efine an abnormal LVEF value on the week 8 assessment.
vents. An independent committee, unaware of the test
esults, reviewed all events. Deaths were categorized as
ardiac or noncardiac. Cardiac deaths were then categorized
s arrhythmic or nonarrhythmic (28). The pre-specified
rimary outcome was cardiac death or resuscitated cardiac
rrest (9,19). All-cause mortality (29) and fatal or nonfatal
ardiac arrest were pre-specified secondary outcomes.
ample size estimate. The study was designed to have 85%
ower to detect at least a 3-fold higher risk of the primary
utcome in patients with abnormalities in both autonomic
one and electrical substrate versus the remaining popula-
ion, assuming that up to 25% of the population would have wbnormalities in both autonomic tone and electrical sub-
trate (18).
tatistical analyses. The capacity of the noninvasive tests
o independently predict the primary and secondary out-
omes was assessed using Cox multivariate models from
hich hazard ratios and 95% confidence intervals (CIs) were
btained (30). Outcome status was obtained on all 322
atients. The proportional hazards assumption was con-
rmed to be valid for each test variable using log-log plots
nd assessment of weighted residuals (31). Given the
otential impact of age, gender, history of prior MI, and
VEF, these variables were pre-specified to be included in
he multivariate models. History of diabetes also was found
o be a significant predictor of outcome and was included in
he models. Noninvasive test results that were not analyz-
ble due to technical reasons were imputed as normal. This
ncluded 14 (4%) acute and 11 (3%) nonacute Holter
ecordings, 17 (5%) acute and 16 (5%) nonacute high-
esolution ECG recordings, 7 (2%) acute and 11 (3%)
onacute exercise TWA tests, and 15 (5%) acute and 11
3%) nonacute BRS assessments. Univariate logistic regres-
ion models were used to calculate the areas under the
eceiver-operator characteristic curve (AUC) for predicting
he primary and secondary outcomes using the aforemen-
ioned dichotomy limits for the noninvasive tests. The time
o development of the primary and secondary outcomes was
raphically displayed by constructing Kaplan-Meier time-
o-event curves, and differences in survival were assessed
sing the log-rank test statistic. Correlation between TWA
ethods was assessed using the Kappa statistic (32). All
nalyses were performed using Stata 9.2MP (Stata Corp.,
ollege Station, Texas). Two-sided p values 0.05 were
onsidered statistically significant.
esults
ollow-up and clinical events. The median duration of
ollow-up was 47 months (interquartile range 37 to 56
onths), and during this time 16 patients (5%) received an
CD because of a resuscitated cardiac arrest (5 patients) or
ersistent severe LV dysfunction. Thirty adjudicated deaths
nd 7 adjudicated resuscitated cardiac arrests occurred
uring follow-up for the 322 patients who completed serial
esting (Fig. 1). Two resuscitated cardiac arrests occurred in
atients with an ICD placed before that event. One patient
ied after the initial event, but before the follow-up nonin-
asive test visit. This death was categorized as cardiac,
onarrhythmic.
haracteristics. The characteristics of the 322 patients
ho underwent serial testing, overall, and by whether they
id versus did not suffer the primary outcome, are shown in
able 1. Most were male, and approximately one-quarter
ad a history of a prior MI. The median time from the prior
I to the index MI was 7 years. Patients who did versus
hose who did not suffer the primary outcome in follow-up
ere similar in most respects. However, a history of diabetes
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utcome.
edication usage, revascularization, and ejection fraction.
articipants reported a high rate of appropriate medical
herapy use at the time of enrollment and throughout
ollow-up (Table 2). Medication usage was similar in
atients who did versus did not develop the primary
utcome in follow-up (exact p values 0.3). Most patients
81%) underwent direct angioplasty at the time of the index
I or revascularization soon after the index MI (Table 1).
19% relative (8% absolute) increase in mean LVEF was
bserved over the initial 8 weeks after MI overall (t test p 
.001). Patients who developed the primary outcome in
ollow-up had significantly smaller increases in LVEF than
id the remaining patients (t test p  0.01).
oninvasive assessment 2 to 4 weeks after MI. No single
easure of autonomic tone and no single measure of
lectrical substrate predicted a significantly higher indepen-
ent risk of the primary outcome in the acute testing period
Patient Characteristics Overall, andStratified by the Developm nt of the Primary Ou
Table 1 Patient Characteristics Overall, andStratified by the Development of th
All Patients
(n  322)
Median age, yrs (IQR) 62 (53–70)
Male, % 85
History of prior MI, % 23
History of diabetes, % 22
History of hypertension, % 45
Median creatinine, mol/l (IQR) 84 (73–97)
Index MI
Median troponin I (IQR) 4.0 (1.2–12.
Q-wave MI, % 68
Anterior location, % 62
Early revascularization, 24 h
Direct angioplasty, % 45
Glycoprotein IIb/IIIa inhibitor, % 34
Thrombolytic therapy, % 21
Later revascularization, 24 h
Delayed angioplasty, % 21
Coronary artery bypass, % 14
Median LV ejection fraction
Within 7 days of index MI (IQR) 0.40 (0.35–0.
Week 8 after index MI (IQR) 0.47 (0.38–0.
*p  0.05; †p  0.01 for comparison of patients who did versus thos
IQR  interquartile range; LV  left ventricular; MI  myocardial in
atient-Reported Medication Use at Time of Enrollment and During
Table 2 Patient-Reported Medication Use at Time of Enrollmen
Enrollment 1
Number of patients with data available 322 322
Antiplatelet agent (%) 99 99
Beta-blocker (%) 92 91
Statin (%) 89 87
Angiotensin-converting enzyme inhibitor 94 90
or angiotensin receptor blocker (%)Table 3, left). Similar results were observed when the
atient who died between test visits was included. The
resence versus absence of frequent VPB, defined as 10
PB/h, was not associated with a higher independent risk
f the primary outcome. Each parameter was limited by
uboptimal predictive utility, as evidenced by modest di-
hotomized AUC values (Table 4, left). Similar results were
bserved for the secondary outcomes.
oninvasive assessment 10 to 14 weeks after MI. Im-
aired BRS, impaired HRT, and abnormal TWA each
redicted a significantly higher independent risk of the
rimary outcome when measured at 10 to 14 weeks after MI
Table 3, right). Each individual parameter had higher
redictive utility in the nonacute versus acute post-MI
eriod, as evidenced by the larger dichotomized AUC values
Table 4, right). Impaired HRV and signal-averaged QRS
idth did not independently predict the primary outcome.
imilar results were observed for the secondary outcomes.
he presence versus absence of frequent VPB was associated
e
ary Outcome
Cardiac Death
or Cardiac Arrest
(n  29)
Remaining Patients
(n  293)
64 (54–71) 62 (53–70)
83 85
34 22
38* 21
55 44
85 (76–100) 84 (72–98)
3.7 (1.0–8.3) 4.1 (1.2–13.2)
59 69
56 63
37 47
31 34
21 21
21 21
10 13
0.38 (0.27–0.40)† 0.40 (0.35–0.45)
0.40 (0.30–0.41)† 0.49 (0.39–0.49)
did not reach primary outcome.
.
w-Up
During Follow-Up
Months After Myocardial Infarction
3 6 12 24 36
316 312 304 280 188
96 94 93 92 94
91 89 91 89 89
87 86 87 86 86
90 88 84 86 86tcom
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utcome (hazard ratio 2.2, 95% CI 0.9 to 5.3, p  0.07).
WA assessment. The TWA methods predicted similarly
igher independent risks of the primary outcome (Table 3).
verall, the agreement between exercise and Holter TWA
Adjusted Hazard Ratios for the Capacity of the IDevelopment of the Prima y Outcome (Cardiac Drre ) in the Acute and Nonacute Earl Post-M
Table 3
Adjusted Hazard Ratios for the Cap
Development of the Primary Outcom
Arrest) in the Acute and Nonacute
Impairment
Autonomic tone
Heart rate variability (SDNN 105 vs. 105 ms)
Baroreflex sensitivity (6.1 vs. 6.1 ms/mm Hg)
Heart rate turbulence (abnormal onset or slope vs. both n
Electrical substrate
Exercise repolarization alternans (non-negative vs. negati
Holter repolarization alternans (5 vs. 5 V)
QRS width (114 vs. 114 ms)
History of diabetes
Left ventricular ejection fraction (0.30 vs. 0.30)
*Cox model hazard ratio adjusted for age, gender, history of previous
MI  myocardial infarction; SDNN  standard deviation of intervals
UC for the Individual Parameters in Predicting therimary Outcome (C rdi c D ath or Resus itatedardiac Arrest) in the Acute and Nonacute E rlyost-MI Periods
Table 4
AUC for the Individual Parameters in Predicting the
Primary Outcome (Cardiac Death or Resuscitated
Cardiac Arrest) in the Acute and Nonacute Early
Post-MI Periods
Impairment
AUC*
2 to 4 Weeks
After Index MI
10 to 14 Weeks
After Index MI
Autonomic tone
Heart rate variability
(SDNN 105 vs. 105 ms)
0.59 0.62
Baroreflex sensitivity
(6.1 vs. 6.1 ms/mm Hg)
0.60 0.66
Heart rate turbulence
(abnormal onset or slope vs.
both normal)
0.58 0.66
Electrical substrate
Exercise repolarization alternans
(non-negative vs. negative)
0.61 0.62
Holter repolarization alternans
(5 vs. 5 V)
0.60 0.62
QRS width (114 vs. 114 ms) 0.55 0.56
History of diabetes — —
Left ventricular ejection fraction
(0.30 vs. 0.30)
0.62 0.62a
Unadjusted logistic regression model for the pre-specified dichotomy limits shown.
AUC  area under the receiver-operator characteristic curve; other abbreviations as in Table 3.ethods was modest (kappa  0.17, p  0.002), but high
greement was observed between the techniques among
atients who developed the primary outcome (kappa 
.49, p  0.009) and those who died (kappa  0.41. p 
.02) or suffered a cardiac arrest (kappa  0.48, p  0.02).
ombined parameter assessment. No combination of im-
aired autonomic tone plus abnormal electrical substrate
easured at 2 to 4 weeks after MI independently predicted
he development of the primary outcome or the secondary
utcomes. When assessed at 10 to 14 weeks after MI, both
mpaired BRS plus abnormal TWA and impaired HRT
lus abnormal TWA each predicted a significantly higher
ndependent risk of the primary outcome (Table 5, left).
he dichotomized AUC values were higher for the combi-
ations that included HRT with either TWA method
ecause of enhanced sensitivity (Table 6). Patients with
mpaired HRT plus abnormal Holter TWA at 10 to 14
eeks after MI were at higher risk for the primary and
econdary outcomes overall and within multiple subgroups,
ncluding stratification by LVEF of 0.30 versus 0.30
eyond 8 weeks after MI (Fig. 2). Similar results were
bserved for the other combinations of parameters. Ad-
ustment for frequent VPB did not alter these relation-
hips. The combination of HRT and exercise TWA at 10
o 14 weeks after MI identified 17 of the 29 (59%)
rimary outcome events. Of the 12 events not predicted
y this combination, 9 were cardiac deaths (4 arrhythmic
nd 5 nonarrhythmic) and 3 were resuscitated cardiac
dual Parameters to Predictor Resuscitated Cardiaciods
of the Individual Parameters to Predict
ardiac Death or Resuscitated Cardiac
Post-MI Periods
Hazard Ratio* (95% Confidence Interval)
p Value
2 to 4 Weeks
After Index MI
10 to 14 Weeks
After Index MI
1.24 (0.50–3.27) 2.15 (0.95–4.87)
0.65 0.066
2.01 (0.76–5.27) 2.71 (1.10–6.67)
0.16 0.030
) 1.42 (0.54–3.75) 2.91 (1.13–7.48)
0.47 0.026
2.42 (0.96–7.71) 2.75 (1.08–7.02)
0.060 0.034
2.09 (0.95–4.60) 2.94 (1.10–7.87)
0.067 0.031
1.35 (0.54–3.36) 1.75 (0.76–3.99)
0.53 0.19
2.68 (1.21–5.92) 2.72 (1.23–5.99)
0.014 0.013
3.06 (1.39–6.74) 3.30 (1.43–7.63)
0.005 0.005
tory of diabetes, and ejection fraction.ndivieathI Per
acity
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Noninvasive Risk Assessment Early Post-MI December 11, 2007:2275–84VEF. Although all patients had LVEF values 0.50 at
tudy entry, only 180 patients (56%) had LVEF values of
0.50, at 8 weeks after MI. An LVEF 0.30 measured at
oth the initial week and at 8 weeks after MI were each
redictive of a higher risk of the primary outcome, but the
UC values for these dichotomy limits were modest (Table
). Logistic regression models were used to assess whether
he noninvasive tests provided distinct information on
rognosis, separate from LVEF (33). Development of the
rimary outcome was used as the dependent variable. The
VEF, Holter TWA voltage, HRT onset, and HRT slope
ere used as continuous independent variables. The AUC
or TWA, HRT onset, and HRT slope at 10 to 14 weeks
fter MI was 0.73. The AUC increased to 0.81 when LVEF
t 8 weeks was added, indicating that LVEF provided
nformation on prognosis additive to the noninvasive tests.
ptimal combination of parameters. Improved diagnos-
ic accuracy, in terms of higher hazard ratio values (Table 5,
ight) and higher AUC values (Table 7) was observed when
n LVEF 0.50 measured at 8 to 10 weeks after MI was
ombined with TWA plus HRT measured at 10 to 14
eeks after MI. Kaplan-Meier curves illustrating the utility
f combining LVEF with TWA and either HRT or BRS
re shown (Fig. 3).
djusted Hazard Ratios for the Capacity of the Noninvasive Paramejection Fr ction to Predict the Development of the Primary Outco
Table 5 Adjusted Hazard Ratios for the Capacity of the NoninvaEjection Fraction to Predict the Development of the Pr
Noninvasive Parameters Alone
Parameters Alone
(10 to 14 Weeks Post-MI)
Hazard Ratio* (95% CI)
p Value
Abnormal exercise TWA  BRS 3.27 (1.42–7.00)
(n  52) vs. others 0.005
Abnormal Holter TWA  BRS 3.17 (1.42–6.94)
(n  53) vs. others 0.005
Abnormal exercise TWA  HRT 3.58 (1.52–7.38)
(n  91) vs. others 0.003
Abnormal Holter TWA  HRT 4.18 (2.06–8.32)
(n  93) vs. others 0.001
Cox model hazard ratio adjusted for age, gender, history of previous MI, history of diabetes, and e
iabetes.
BRS  baroreflex sensitivity; CI  confidence interval; HRT  heart rate turbulence; LVEF  lef
UC, Test Characteristics, and Accuracy of the Noninvasive Paramo Predic the Primary Outcome (Cardiac Death or Resu citated Ca
Table 6 AUC, Test Characteristics, and Accuracy of the Noninvto Predict the Primary Outcome (Cardiac Death or Res
Parameters
(10 to 14 Weeks Post-MI)
Area Under the
ROC Curve* Sens
Abnormal exercise TWA  BRS
(n  52) vs. others
0.65 45 (3
Abnormal Holter TWA  BRS
(n  53) vs. others
0.65 45 (3
Abnormal exercise TWA  HRT
(n  91) vs. others
0.70 59 (5
Abnormal Holter TWA  HRT
(n  93) vs. others
0.71 62 (5Unadjusted logistic regression model for the pre-specified dichotomy limits (see Table 4).
Abbreviations as in Tables 4 and 5.iscussion
his is the first prospective study to assess the capacity of
ombined assessment of autonomic tone plus cardiac elec-
rical substrate to predict the development of serious out-
omes after MI. Impaired HRT plus abnormal TWA
easured at 10 to 14 weeks after MI best identified patients
t risk. This combination reliably predicted a higher risk of
ardiac death or cardiac arrest, a higher risk of death from
ny cause, and a higher risk of fatal or nonfatal cardiac
rrest.
emodeling after MI and rationale for combined assess-
ent. Similar to others (34,35), we observed a significant
ncrease in LVEF over the initial 2 months after MI. This
ikely reflects the frequent use of early revascularization
trategies and medications known to promote favorable LV
emodeling (34). It is not surprising that the diagnostic
alue of the noninvasive parameters varied at 2 to 4 weeks
ersus 10 to 14 weeks after MI. To our knowledge, the
iagnostic value of these parameters at serial points early
fter MI has not been reported previously.
Abnormalities of electrical substrate are thought to facil-
tate the initiation of serious arrhythmias, whereas modu-
ating factors, such as autonomic tone, promote arrhythmia
Alone and Combined Withardiac Death or R suscitated Cardiac Arrest)
Parameters Alone and Combined With
Outcome (Cardiac Death or Resuscitated Cardiac Arrest)
Noninvasive Parameters Plus LVEF
Parameters Plus LVEF
(Beyond 8 Weeks Post-MI)
Hazard Ratio† (95% CI)
p Value
ormal exercise TWA  BRS  LVEF 0.50 5.22 (2.25–12.13)
 31) vs. others 0.001
ormal Holter TWA  BRS  LVEF 0.50 4.77 (2.08–10.90)
 32) vs. others 0.001
ormal exercise TWA  HRT  LVEF 0.50 5.08 (2.17–11.89)
 64) vs. others 0.001
ormal Holter TWA  HRT  LVEF 0.50 6.22 (2.88–13.42)
 55) vs. others 0.001
fraction. †Cox model hazard ratio adjusted for age, gender, history of previous MI, and history of
cular ejection fraction; MI  myocardial infarction; TWA  T-wave alternans.
Arrest) at 10 to 14 Weeks Post-MI
Parameters
ated Cardiac Arrest) at 10 to 14 Weeks Post-MI
acteristics (95% CI) Predictive Accuracy (95% CI)
Specificity Positive Negative
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one and electrical substrate would be anticipated to opti-
ally identify patients at risk of serious arrhythmias. Our
esults show that post-MI patients with abnormal TWA
lus either impaired BRS or HRT have a significantly
igher risk of serious events compared with patients without
oth of these abnormalities. This finding was consistent
ithin multiple patient subgroups.
echniques evaluated in the REFINE study. Baroreflex
ensitivity is a reliable measure of cardiac autonomic tone
9), and HRT is closely linked to BRS (37). Heart rate
urbulence is often described in terms of the presence or
bsence of the normal acceleration in heart rate that follows
VPB (HRT onset) and the magnitude of the subsequent
lowing in heart rate (HRT slope) (25). Repolarization
lternans is a sensitive marker of underlying abnormalities in
lectrical structure. It is often assessed as a sustained,
icrovolt phenomenon with exercise (26). A negative exer-
ise TWA result identifies patients at low risk of serious
vents, but a non-negative result is limited by poor positive
redictive accuracy. Repolarization alternans can also be
ssessed as a transient phenomenon using ambulatory ECG
ecordings (13), but only sparse prospective data are avail-
ble (38). We found similar predictive utility with exercise
Figure 2 Predictive Value in Subgroups
The unadjusted risk of the primary outcome of cardiac death or resuscitated cardi
all-cause mortality (C) for patients with versus without both abnormal heart rate tu
and 95% confidence interval for the hazard ratio in subgroups and overall are show
UC, Test Characteristics, and Accuracy of the Noninvasive Paramith LVEF to Predict the Primary O tcome (Cardiac De th or Resu
Table 7 AUC, Test Characteristics, and Accuracy of the NoninvWith LVEF to Predict the Primary Outcome (Cardiac D
Parameters
(Beyond 8 Weeks Post-MI) Dichotomized AUC*
Abnormal exercise TWA  BRS  LVEF 0.50
(n  31) vs. others
0.71
Abnormal Holter TWA  BRS  LVEF 0.50
(n  32) vs. others
0.71
Abnormal exercise TWA  HRT  LVEF 0.50
(n  64) vs. others
0.72
Abnormal Holter TWA  HRT  LVEF 0.50
(n  55) vs. others
0.74Unadjusted logistic regression model for the pre-specified dichotomy limits (see Table 4).
Abbreviations as in Tables 4 and 6.ersus Holter assessment, but the overall level agreement
etween methods was modest. This indicates that the 2
ethods may provide different prognostic information. The
easons for this may relate to when the tests were performed
during exercise vs. immediately after exercise), the size of
he sampling window (128 beats with exercise TWA vs. 32
eats with Holter TWA), the level of ambient noise, or
ther factors.
rior studies assessing the utility of combined parameter
valuation. Combined evaluation of HRV plus signal-
veraged QRS in the initial month after MI was shown to
nhance risk prediction in prior studies (15,18). However,
hese prior data were obtained in a different era of MI
anagement and likely do not reflect contemporary prac-
ice. Similar to another study of contemporarily treated
atients (19), combined assessment of autonomic tone plus
ignal-averaged ECG did not reliably predict outcome in
he REFINE study.
he REFINE study versus other noninvasive risk strat-
fication studies. Individual measures of severe autonomic
mpairment, when measured in the initial month after MI,
ave been shown to identify patients at risk of serious
vents. However, each is limited by low sensitivity. In the
EFINE study the combination of impaired HRT plus
st (A) and the secondary outcomes of fatal or nonfatal cardiac arrest (B) and
ce and abnormal Holter repolarization alternans are shown. The central estimate
EF  left ventricular ejection fraction; MI  myocardial infarction.
Combinedted Cardiac Arrest) Beyond 8 Weeks Post-MI
Parameters Combined
or Resuscitated Cardiac Arrest) Beyond 8 Weeks Post-MI
Characteristics (95% CI) Predictive Accuracy (95% CI)
Sensitivity Specificity Positive Negative
37 (32–42) 93 (90–96) 32 (27–37) 94 (92–97)
37 (32–42) 93 (90–95) 31 (26–36) 94 (92–97)
52 (46–57) 83 (79–87) 23 (17–26) 95 (92–97)
55 (50–61) 86 (82–90) 27 (22–32) 96 (93–98)ac arre
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dentified a similar risk of cardiac death to that of markedly
bnormal BRS alone (9), but a larger proportion of patients
t risk were identified (65% vs. 35%; exact p  0.03). The
ethod used in the REFINE study also identified a
imilarly high risk of cardiac death or cardiac arrest to severe
RT alone (14), but more patients at risk were identified
sing HRT plus TWA (62% vs. 32%; exact p  0.03). The
isk of death associated with HRT plus TWA is similar to
hat found for severe deceleration capacity alone (19), but
ore patients at risk are identified using HRT plus TWA
ersus deceleration capacity (57% vs. 30%; exact p 0.006).
oninvasive parameters and EF. An LVEF 0.30 mea-
ured at 8 to 10 weeks after MI predicted a 3-fold higher
isk of the primary outcome, but only 31% of patients who
eveloped the primary outcome had an LVEF 0.30. The
ombination of impaired HRT plus abnormal TWA pre-
icted a 4-fold risk of the primary outcome and identified
significantly larger proportion of patients (exact p 
.034). The predictive utility of TWA combined with either
RT or BRS was consistent among subgroups, including
atients with LVEF values 0.30 versus 0.30 beyond the
nitial 8 weeks after MI (Fig. 2). Moreover, LVEF mea-
ured at 8 to 10 weeks after MI provided information on risk
hat was additive to that provided by HRT plus TWA. The
0% of patients with impaired HRT, abnormal exercise
WA, and an LVEF 0.50 beyond 8 weeks after MI had
30% risk of cardiac death or cardiac arrest and a 27% risk
f death over 4 years versus a 5% risk in the remaining 80%
f patients. In contrast to other risk assessment approaches,
he combination of HRT plus Holter TWA identified the
ajority of patients destined to suffer a cardiac arrest (67%)
r die of any cause (57%).
isk assessment in clinical practice. We found that a
elatively simple testing protocol that included assessment of
VEF, a 24-h ambulatory ECG monitor, and a low-level
xercise test beyond 8 weeks after MI readily identified the
ajority of patients destined to suffer serious events. Similar
esults were obtained with assessment of LVEF and a 24-h
igh resolution Holter. This simple, easy-to-implement
creening strategy has significant clinical appeal. However,
his approach, particularly Holter-based TWA assessment,
equires validation.
tudy limitations. This was a carefully conducted cohort
tudy in a well-described group of contemporarily treated
ost-MI patients. Pre-specified rigorous methods were
sed, and the end points were independently adjudicated.
owever, this was not a randomized trial, and our results
re subject to both known and unknown factors. Despite the
pparent detection of patients at risk for serious arrhythmic
vents with the combination of TWA plus HRT in RE-
INE, a larger study found that HRT was not a specific
arker for arrhythmic death (39). Exercise TWA has been
hown to be predictive of death or serious arrhythmias (26),
nd may be a more specific marker for arrhythmic deathFigure 3 Risk Dichotomization
The risk of the primary outcome of cardiac death or resuscitated cardiac arrest (A)
and secondary outcomes of fatal or nonfatal cardiac arrest (B) and all-cause mor-
tality (C) among patients with impaired autonomic tone, measured using either
baroreflex sensitivity or heart rate turbulence, plus abnormal repolarization alter-
nans and an ejection fraction below 0.50 versus the remaining patients are
shown. Numbers of patients in each group at the time points are indicated below
each graph. TWA  T-wave alternans; other abbreviations as in Figure 2.27). However, it is well known that categorizing deaths as
a
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ortality is considered by many to be a more appropriate
utcome for assessing therapeutic efficacy (29). Nonetheless,
he combination of abnormal TWA plus impaired auto-
omic tone reliably predicted the risk of the primary
utcome of cardiovascular death or resuscitated cardiac
rrest, as well as the secondary outcomes of all-cause
ortality and fatal or nonfatal cardiac arrest in the REFINE
tudy.
onclusions
atients with mild or greater LV dysfunction beyond the
nitial 8 weeks after MI who have both abnormal TWA and
mpaired autonomic tone are at greatly increased risk of
erious events in follow-up.
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